Detalhe da pesquisa
1.
Prevalence and Clinical Impact of SARS-CoV-2 Silent Carriers Among Actively Treated Patients with Cancer During the COVID-19 Pandemic.
Oncologist
; 26(4): 341-347, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33355953
2.
Impact of influenza vaccination on survival of patients with advanced cancer receiving immune checkpoint inhibitors (INVIDIa-2): final results of the multicentre, prospective, observational study.
EClinicalMedicine
; 61: 102044, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37434748
3.
SARS-CoV-2 infection and adverse events in patients with cancer receiving immune checkpoint inhibitors: an observational prospective study.
J Immunother Cancer
; 9(2)2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33593827
4.
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a multicenter prospective observational study (INVIDIa-2).
J Immunother Cancer
; 9(5)2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34016723
5.
Risk Prediction and New Prophylaxis Strategies for Thromboembolism in Cancer.
Cancers (Basel)
; 12(8)2020 Jul 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32726933
6.
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG.
Ther Adv Med Oncol
; 12: 1758835920968463, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33224275